Details for New Drug Application (NDA): 062727
✉ Email this page to a colleague
NDA 062727 describes TOTACILLIN-N, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the TOTACILLIN-N profile page.
The generic ingredient in TOTACILLIN-N is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
The generic ingredient in TOTACILLIN-N is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
Summary for 062727
| Tradename: | TOTACILLIN-N |
| Applicant: | Glaxosmithkline |
| Ingredient: | ampicillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062727
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Dec 19, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Dec 19, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
